Related Experiment Videos
Antihypertensive treatment: past, present and future
1Cattedra di Medicina Interna I, Università di Milano, Ospedale S. Gerardo dei Tintori, Italy.
Summary
Hypertension treatment guidelines have evolved from a stepwise approach to a more individualized strategy focusing on cardiovascular risk. Future guidelines will likely emphasize combination therapy and non-pharmacological methods for managing high blood pressure.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Hypertension treatment guidelines have evolved significantly since 1977.
- Early guidelines focused on a 'stepped care' approach, starting with diuretics and adding drugs sequentially.
- Subsequent revisions broadened initial drug choices to four classes, including beta-blockers, ACE inhibitors, and calcium antagonists.
Purpose of the Study:
- To review the evolution of hypertension treatment guidelines.
- To compare past and present approaches to managing high blood pressure.
- To anticipate future trends in hypertension pharmacotherapy and non-pharmacological interventions.
Main Methods:
- Analysis of historical and contemporary hypertension treatment guidelines.
- Comparison of key features across different guideline iterations.
- Identification of trends in drug selection, treatment initiation, and therapeutic goals.
Main Results:
- Past guidelines emphasized a 'stepped care' model, starting with thiazide diuretics.
- Current guidelines (WHO/ISH, JNC) advocate for broader initial drug classes and consider overall cardiovascular risk.
- Differences exist in target blood pressure and initial drug choices between major current guidelines.
Conclusions:
- The 'stepped care' approach remains relevant but will likely incorporate more combination therapy.
- Future hypertension management will likely increase focus on non-pharmacological interventions.
- Baseline blood pressure values will play a greater role in determining when to initiate drug treatment.